King Luther Capital Management Corp Sells 5,396 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

King Luther Capital Management Corp reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 16.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 26,850 shares of the pharmacy operator’s stock after selling 5,396 shares during the period. King Luther Capital Management Corp’s holdings in Walgreens Boots Alliance were worth $325,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Pineridge Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Quest Partners LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $30,000. 1832 Asset Management L.P. boosted its holdings in shares of Walgreens Boots Alliance by 282.1% in the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 900 shares during the period. New Covenant Trust Company N.A. purchased a new position in shares of Walgreens Boots Alliance in the first quarter valued at $35,000. Finally, First Personal Financial Services raised its stake in shares of Walgreens Boots Alliance by 260.0% during the 1st quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 1,300 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on WBA shares. JPMorgan Chase & Co. cut their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, August 30th. Royal Bank of Canada reduced their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. Morgan Stanley lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research note on Friday, June 28th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Finally, Evercore ISI decreased their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $14.73.

Check Out Our Latest Research Report on WBA

Walgreens Boots Alliance Price Performance

WBA opened at $8.71 on Monday. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $7.52 billion, a P/E ratio of -1.29, a PEG ratio of 1.02 and a beta of 0.70. The stock has a 50-day moving average price of $10.29 and a 200-day moving average price of $14.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.46 and a 12-month high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 EPS. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 11.48%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.